Investing.com - Hansa Biopharma reported on Thursday third quarter earnings that beat analysts' forecasts and revenue that topped expectations.
Hansa Biopharma announced earnings per share of kr-3.45 on revenue of kr67.08. Analysts polled by Investing.com anticipated EPS of kr-3.80 on revenue of kr26.69M.
Hansa Biopharma shares are up 14% from the beginning of the year , still down 53.53% from its 52 week high of kr115.55 set on Thursday, October 21, 2021.
Stay up-to-date on all of the upcoming earnings reports by visiting Investing.com's earnings calendar